In human breast cancer cells, SSTR1 and SSTR5 subtypes heterodimerize with epidermal growth factor receptor and modulate the downstream MAPK pathway in an agonist-dependent manner [198]. This evidence concerns the gene SSTR5 and breast carcinoma.